Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion.
GH plays a major role in the regulation of lipid metabolism and alterations in GH axis elicit major changes in fat distribution and mobilization. For example, in patients with GH deficiency (GHD) or in mice lacking the GH receptor, the percentage of fat is increased. In addition to the direct actions of GH on lipid metabolism, current evidence indicates that ghrelin, a stomach-derived peptide hormone with potent GH secretagogue action, increases lipogenesis in white adipose tissue (WAT) through a hypothalamic-mediated mechanism. Still, the mechanism by which GH tone modulates ghrelin actions on WAT remains unclear. Here we investigated the effect of central ghrelin administration on lipid metabolism in lipogenic tissues (liver and WAT) in the absence of GH, by using a model for the study of GHD, namely the spontaneous dwarf rat, which shows increased body fat. Our data demonstrate that central chronic ghrelin administration regulates adipose lipid metabolism, mainly in a GH-independent fashion, as a result of increased mRNA, protein expression, and activity levels of fatty acid metabolism enzymes. On the contrary, central ghrelin regulates hepatic lipogenesis de novo in a GH-independent fashion but lipid mobilization in a GH-dependent fashion because carnitine palmitoyltransferase 1 was decreased only in wild-type Lewis rats. These findings suggest the existence of a new central nervous system-based neuroendocrine circuit, regulating metabolic homeostasis of adipose tissue. Understanding the molecular mechanism underlying the interplay between GH and ghrelin and their effects on lipid metabolism will provide new strategies for the design and development of suitable drugs for the treatment of GHD, obesity, and its comorbidities.
Sangiao-Alvarellos
Susana
S
Department of Medicine, School of Health Science, University of A Coruña, A Coruña, Spain. ssangiao@udc.es
Vázquez
María J
MJ
Varela
Luis
L
Nogueiras
Rubén
R
Saha
Asish K
AK
Cordido
Fernando
F
López
Miguel
M
Diéguez
Carlos
C
D017667:Adipocytes / Q000378:metabolism*; D052436:Adipose Tissue, White / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002490:Central Nervous System; D004435:Eating / Q000187:drug effects; D005215:Fasting / Q000097:blood; D054439:Ghrelin / Q000008:administration & dosage / Q000097:blood*; D013006:Growth Hormone / Q000378:metabolism*; D006706:Homeostasis; D007276:Injections, Intraventricular; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew
D054439:Ghrelin; D013006:Growth Hormone